| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-05 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |